Impact of oncology pharmacist-managed oral anticancer therapy in patients with chronic myelogenous leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 741, doi. 10.1177/1078155215608523
- By:
- Publication type:
- Article
Works by Lam, Masha S. H.
Results: 5
1
2
Second-generation thrombopoietin agents for treatment of chronic idiopathic thrombocytopenic purpura in adults.
- Published in:
- Journal of Oncology Pharmacy Practice, 2010, v. 16, n. 2, p. 89, doi. 10.1177/1078155209337668
- By:
- Publication type:
- Article
3
Extemporaneous Compounding of Oral Liquid Dosage Formulations and Alternative Drug Delivery Methods for Anticancer Drugs.
- Published in:
- Pharmacotherapy, 2011, v. 31, n. 2, p. 164, doi. 10.1592/phco.31.2.164
- By:
- Publication type:
- Article
4
Pertuzumab for the treatment of human epidermal growth factor receptor type 2-positive metastatic breast cancer.
- Published in:
- American Journal of Health-System Pharmacy, 2013, v. 70, n. 18, p. 1579, doi. 10.2146/ajhp120735
- By:
- Publication type:
- Article
5
Capecitabine-associated cerebellar ataxia.
- Published in:
- American Journal of Health-System Pharmacy, 2008, v. 65, n. 21, p. 2032, doi. 10.2146/ajhp080094
- By:
- Publication type:
- Article